Safety and efficacy of intracameral injection of dexamethasone and moxifloxacin at the end of cataract surgery

Albialy, Hany Abdalhafiz; Wagih, Mostafa Mohammed; Gouda, Doaa Mohammed; Eid, Ashraf Mahrous

doi:10.21608/zumj.2019.19166.1616

Safety and efficacy of intracameral injection of dexamethasone and moxifloxacin at the end of cataract surgery

Document Type : Original Article

Authors

¹ Departmemt of ophthalmology,faculity of medicine , Zagazig university0000

² Ophthalmology Department, Zagazig University, Zagazig, Egypt

³ Zagazig ophthalmic hospital, Zagazig, Egypt

⁴ ophthalmology department, faculty of medicine, zagazig university

10.21608/zumj.2019.19166.1616

Abstract

Background:
To evaluate whether intracameral dexamethasone – moxifloxacin can safely and effectively reduce the postoperative inflammation, guard against endophthalmitis and improve surgical outcomes after cataract surgery.
Methods:
Prospective randomized comparative study included 200 eyes of 200 Patients underwent uncomplicated phacoemulsification . 100 eyes were injected intracamerally with 0.1 ml moxifloxacin 0.5% and 0.4 mg dexamethasone at the end of surgery while the other 100 eyes as a control group received intracameral placebo injection. Outcomes were measured on first postoperative day and weekly for one month by visual acuity assessment, slit lamp examination, intraocular pressure , endothelial cell density and any postoperative complications.
Results:
Aqueous cells on the first postoprative day in group I : five eyes had 2+, and 7 eyes had 1+ with no eyes of +3 or more. After 1 week , all eyes had no anterior chamber cells. In group II, the first postoperative day showed 11 eyes with 3+, 15 eyes had 2+, 8 eyes had 1+. One week postoperatively , only 3 eyes had +1 aquous cells. All eyes of both groups had no detected anterior chamber cells at subsequent follow up visits. The mean postoperative endothelial cell density in injectedgroup was 2274.15 cells/mm2 ±330.09. after one month . There was no significant effect on IOP values with no detected long-term complications .
Conclusion:
Intracameral dexamethasone- moxifloxacin injected at the end of cataract surgery reduces the postoperative AC cells significantly and improves patient's compliance in early postoperative follow period with no risk of IOP elevation.

Keywords

Main Subjects